MAP2K1 mutations do not have a well-described association with T-cell neoplasms but MAP2K1 C121S is known to be an activating mutation25 and has been observed in cases of melanoma, gastrointestinal adenocarcinomas, histiocytic neoplasms, and others24,26. The gene discussed is MAP2K1; the disease is histiocytic neoplasm.